| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695600 | International Journal of Gynecology & Obstetrics | 2016 | 5 Pages |
Abstract
cffDNA screening should be used to optimize IDT uptake in pregnancies with a risk score of 1:101-1:1000. The selective power of the FCT diminishes beyond the 1:1001 score and cffDNA screening cannot yet be recommended routinely.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Semir Kose, Dilek Cımrın, Nuri Yıldırım, Ozge Aksel, Pembe Keskinoglu, Elcin Bora, Tufan Cankaya, Sabahattin Altunyurt,